Zimmer Biomet Holdings Stock Today
| ZBH Stock | USD 107.35 1.37 1.29% |
PerformanceVery Weak
| Odds Of DistressLow
|
Zimmer Biomet is trading at 107.35 as of the 25th of February 2025. This is a 1.29 percent increase since the beginning of the trading day. The stock's open price was 105.98. Zimmer Biomet has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Note, on December 6, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Zimmer Biomet Holdings's common stock.
Business Domain Health Care Equipment & Services | IPO Date 25th of July 2001 | Category Healthcare | Classification Health Care |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. The company has 199.07 M outstanding shares of which 7.42 M shares are at this time shorted by investors with about 4.39 days to cover. More on Zimmer Biomet Holdings
Moving together with Zimmer Stock
Moving against Zimmer Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Zimmer Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Larry Glasscock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Obamacare Repeal (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Zimmer Biomet Holdings Inc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsZimmer Biomet can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zimmer Biomet's financial leverage. It provides some insight into what part of Zimmer Biomet's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zimmer Biomet Holdings (ZBH) is traded on New York Stock Exchange in USA. It is located in 345 East Main Street, Warsaw, IN, United States, 46580 and employs 33 people. Zimmer Biomet is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 21.1 B. Zimmer Biomet Holdings runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 199.07 M outstanding shares of which 7.42 M shares are at this time shorted by investors with about 4.39 days to cover.
Zimmer Biomet Holdings has about 375.7 M in cash with 1.58 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.71.
Check Zimmer Biomet Probability Of Bankruptcy
Ownership AllocationZimmer Biomet Holdings retains a total of 199.07 Million outstanding shares. The majority of Zimmer Biomet outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zimmer Biomet Holdings to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zimmer Biomet Holdings. Please pay attention to any change in the institutional holdings of Zimmer Biomet Holdings as this could imply that something significant has changed or is about to change at the company. Please note that on December 6, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Zimmer Biomet Holdings's common stock.
Check Zimmer Ownership Details
Zimmer Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Franklin Resources Inc | 2024-12-31 | 3.5 M | |
| Allspring Global Investments Holdings, Llc | 2024-12-31 | 2.6 M | |
| Northern Trust Corp | 2024-12-31 | 2.4 M | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.2 M | |
| Norges Bank | 2024-12-31 | 2 M | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 2 M | |
| Ubs Asset Mgmt Americas Inc | 2024-12-31 | 1.8 M | |
| Hotchkis & Wiley Capital Management Llc | 2024-12-31 | 1.7 M | |
| Boston Partners Global Investors, Inc | 2024-12-31 | 1.6 M | |
| Vanguard Group Inc | 2024-12-31 | 22.9 M | |
| Dodge & Cox | 2024-12-31 | 19.1 M |
Zimmer Biomet Historical Income Statement
Zimmer Stock Against Markets
Zimmer Biomet Corporate Directors
| Arthur Higgins | Independent Director | Profile | |
| Michael Michelson | Independent Director | Profile | |
| Christopher Begley | Lead Independent Director | Profile | |
| Betsy Bernard | Independent Director | Profile |
Already Invested in Zimmer Biomet Holdings?
The danger of trading Zimmer Biomet Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zimmer Biomet is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zimmer Biomet. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zimmer Biomet Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Dividend Share 0.96 | Earnings Share 4.43 | Revenue Per Share | Quarterly Revenue Growth 0.043 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.